Related references
Note: Only part of the references are listed.Monitoring of residual disease by next-generation deep-sequencing of RUNX1 mutations can identify acute myeloid leukemia patients with resistant disease
A. Kohlmann et al.
LEUKEMIA (2014)
A role for RUNX1 in hematopoiesis and myeloid leukemia
Motoshi Ichikawa et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Recognizing familial myeloid leukemia in adults
Eric M. Nickels et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)
Norio Shiba et al.
BLOOD (2012)
Extensive gene deletions in Japanese patients with Diamond-Blackfan anemia
Madoka Kuramitsu et al.
BLOOD (2012)
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
Philipp A. Greif et al.
BLOOD (2012)
C-terminal mutation of RUNX1 attenuates the DNA-damage repair response in hematopoietic stem cells
Y. Satoh et al.
LEUKEMIA (2012)
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins
Akihide Yoshimi et al.
BLOOD (2011)
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
Rachel Emma Dickinson et al.
BLOOD (2011)
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Amy P. Hsu et al.
BLOOD (2011)
Familial myelodysplastic syndromes: a review of the literature
Elena Liew et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
Pia Ostergaard et al.
NATURE GENETICS (2011)
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
Christopher N. Hahn et al.
NATURE GENETICS (2011)
Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia
Su-Jiang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
P53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death
Ondrej Krejci et al.
BLOOD (2008)
A novel RUNX1 mutation in familial platelet disorder with propensity to develop myeloid malignancies
Keita Kirito et al.
HAEMATOLOGICA (2007)
RUNX1 gene mutation in primary myelodysplastic syndrome -: the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
Chien-Yuan Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
CDC25 phosphatases in cancer cells: key players? Good targets?
Rose Boutros et al.
NATURE REVIEWS CANCER (2007)
The Runx genes:: lineage-specific oncogenes and tumor suppressors
ER Cameron et al.
ONCOGENE (2004)
Functional cdc25C dual-specificity phosphatase is required for S-phase entry in human cells
P Turowski et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis
J Michaud et al.
BLOOD (2002)
The leukemia-associated AML1 (Runx1)-CBFβ complex functions as a DNA-induced molecular clamp
J Bravo et al.
NATURE STRUCTURAL BIOLOGY (2001)
Share Paper
